409A Valuation for a Multi-Provider Behavioral Health Group

Incentive stock options are reserved for employees under the tax code, so a group with a meaningful share of 1099 therapists or counselors can't simply extend the same option grant to everyone regardless of classification. Contractor clinicians can still receive equity, typically structured as nonqualified options or profits interests depending on your entity type, but the plan design has to accommodate two different instruments rather than treating every provider identically.

Get a clean count of who's W-2 versus 1099 before you design or update your equity plan, since that split determines the whole structure, not just a detail your attorney handles after the fact.

Match the equity instrument to each clinician's classification:

• W-2 employee clinicians can hold incentive stock options, which the tax code reserves for employees only.
• 1099 therapists and counselors can still receive equity, typically as nonqualified options or profits interests depending on your entity structure.
• A contractor who moves to a W-2 role keeps the original nonqualified grant, and only new grants can use the employee-only structure.
• Talk to your attorney about the right instrument for each person before granting anything.

A behavioral health group that grew by recruiting individual clinicians over time, rather than through outside investment rounds, often has a cap table that looks nothing like a typical venture-backed company's: fewer large blocks of preferred stock, more smaller grants spread across a wider group of providers who joined at different points and different valuations. That pattern isn't a problem, but it does mean your appraiser should understand the group's actual growth story rather than assume a standard startup trajectory when projecting forward.

Walk your appraiser through how the practice actually grew, provider by provider, rather than letting them default to assumptions built for a differently financed business.

A behavioral health practice's revenue tracks clinician capacity and utilization more directly than most service businesses, since each provider can only see so many clients in a week, and no-show or late-cancellation rates eat directly into billable time. An appraiser projecting growth needs to understand whether your growth plan depends on adding more providers, on improving utilization among existing ones, or both, since those paths carry different risk and different capital needs.

If you've made real progress on reducing no-shows, through reminder systems or waitlist management, quantify that improvement and bring it to the conversation rather than leaving it as an assumed but undocumented gain.

A practice that shifted a meaningful share of sessions to telehealth typically carries lower real estate and overhead costs per session, which can genuinely improve margin, but it also introduces regulatory questions that a fully in-person practice doesn't face: state licensure requirements for treating clients across state lines, and payer reimbursement parity rules that vary by state and aren't guaranteed to stay as favorable as they are today. An appraiser modeling forward margins off a telehealth-heavy mix should understand both sides of that tradeoff.

If your telehealth mix has grown substantially, document what share of revenue it represents now versus a few years ago, and be candid with your appraiser about any state licensure or payer parity risk that could affect that revenue if rules change. A margin improvement built on a regulatory environment that could shift is worth flagging rather than assuming it's permanent.

A group with a straightforward single-entity structure and equity limited to founding clinicians and a handful of senior providers fits reasonably well with Carta's simpler, faster-to-set-up model. Once you're managing a larger number of smaller grants across a wide provider base, with a genuine mix of W-2 and 1099 instruments to track, Shareworks' administration tends to handle that volume and complexity with less manual cleanup, particularly as the group keeps adding providers over time.

Say a 1099 clinician who's been with the group for several years, and who already holds nonqualified options, moves to a W-2 role as the practice grows. That transition doesn't automatically convert their existing grant into incentive stock options; the original instrument generally stays what it was, and any new grant going forward can use the employee-only structure. The common mistake is assuming a change in employment status automatically upgrades existing equity; it doesn't, and your attorney should confirm exactly how the transition affects both the old grant and any new one before you communicate anything to the clinician.

A senior clinician offered a partnership stake is, in effect, buying into a business whose value depends heavily on provider capacity and utilization, the same dynamics that determine day-to-day revenue. Price that buy-in using a formula consistent with how the rest of the group's equity was valued, rather than a one-off number negotiated separately, so future partners can trust that the process was applied consistently rather than case by case.